Capital Impact Advisors, LLC - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital Impact Advisors, LLC ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2023$177,425
+5.4%
7,2330.0%0.20%
-5.3%
Q1 2023$168,312
-49.6%
7,233
-45.2%
0.21%
-36.8%
Q4 2022$333,991
-7.2%
13,1960.0%0.33%
-9.2%
Q3 2022$360,000
+17.3%
13,196
+9.4%
0.36%
+26.4%
Q2 2022$307,000
-22.5%
12,066
-21.6%
0.28%
-1.4%
Q1 2022$396,00015,3980.29%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$14,609,16117.42%
SB INVESTMENT ADVISERS (UK) LTD 16,684,041$156,329,4641.29%
Octagon Capital Advisors LP 325,050$3,045,7190.47%
SECTOR GAMMA AS 148,538$1,391,8010.36%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 1,345,635$12,608,6000.31%
ALGERT GLOBAL LLC 449,685$4,2140.20%
Quantamental Technologies LLC 18,519$173,5230.16%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 47,000$439,9200.15%
DUALITY ADVISERS, LP 123,871$1,160,6710.14%
Empowered Funds, LLC 385,135$3,608,7150.11%
View complete list of VIR BIOTECHNOLOGY INC shareholders